Big Pharma — sleep apnoea

New neural network enables easy screening of sleep apnoea in patients with cerebrovascular disease A new neural network developed by researchers at the University of Eastern Finland and Kuopio University Hospital enables an easy and accurate assessment of sleep apnoea severity in patients with cerebrovascular disease. The assessment is automated and based on a simple nocturnal pulse oximetry, making it possible to easily screen for sleep apnoea in stroke units. Up to 90% of patients experiencing a stroke have sleep apnoea, according to earlier studies conducted at Kuopio University Hospital. If left untreated, sleep apnoea can reduce the quality of...

COVID-19 patients with sleep apnoea could be at additional risk   Relationship between obstructive sleep apnoea and poorer outcomes from COVID-19 identified in systematic review of studies by University of Warwick Researchers advise that people with obstructive sleep apnoea should take the necessary precautions to reduce their exposure and follow their treatment plan diligently 5 million people in the UK currently diagnosed with the condition, but up to 85% of people could be undiagnosed Researchers call for better recording and more data on the condition   People who have been diagnosed with obstructive sleep apnoea could be at increased risk...